心脉医疗
(688016)
| 流通市值：133.14亿 | | | 总市值：133.14亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 969,564,236.7 | 787,174,656.18 | 358,081,405.15 | 1,187,204,459.56 |
| 营业收入 | 969,564,236.7 | 787,174,656.18 | 358,081,405.15 | 1,187,204,459.56 |
| 二、营业总成本 | 443,293,120.87 | 323,455,886.28 | 145,767,427.87 | 641,267,223.89 |
| 营业成本 | 237,583,526.66 | 184,417,127.73 | 84,093,698.7 | 279,577,994.84 |
| 税金及附加 | 8,728,749.79 | 8,236,853.67 | 3,662,271.82 | 12,032,019.57 |
| 销售费用 | 92,308,589.63 | 62,389,783 | 26,583,495.65 | 130,156,250.56 |
| 管理费用 | 45,472,931.03 | 28,319,058.82 | 12,594,236.71 | 55,030,462.74 |
| 研发费用 | 71,250,689.15 | 48,673,142.99 | 23,190,117.2 | 172,884,268.43 |
| 财务费用 | -12,051,365.39 | -8,580,079.93 | -4,356,392.21 | -8,413,772.25 |
| 其中:利息费用 | 1,155,169.67 | 832,596.11 | 443,130.69 | 1,821,925.57 |
| 其中:利息收入 | 13,545,716.85 | 9,266,687.77 | 4,634,160.01 | 9,261,266.14 |
| 加:投资收益 | 79,578,889.01 | 16,457,857.09 | 7,127,681.04 | 9,148,489.85 |
| 资产减值损失(新) | -3,773,317.77 | -2,101,578.71 | -1,741,164.06 | -6,354,297.12 |
| 信用减值损失(新) | -3,210,007.36 | -10,025,162.37 | -2,329,613.74 | -1,336,190.64 |
| 其他收益 | 38,923,557.36 | 4,691,353.76 | 2,396,063.5 | 26,459,104.81 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 637,790,237.07 | 472,741,239.67 | 217,766,944.02 | 573,854,342.57 |
| 加:营业外收入 | 61,575.07 | 61,475.06 | 54,362.95 | 334,557.66 |
| 减:营业外支出 | 1,622,406.33 | 1,647,476.59 | 1,060,608.94 | 1,921,912.31 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 636,229,405.81 | 471,155,238.14 | 216,760,698.03 | 572,266,987.92 |
| 减:所得税费用 | 89,052,238.3 | 71,574,584.17 | 33,894,586.82 | 85,050,009.75 |
| 六、净利润 | 547,177,167.51 | 399,580,653.97 | 182,866,111.21 | 487,216,978.17 |
| 持续经营净利润 | 547,177,167.51 | 399,580,653.97 | 182,866,111.21 | 487,216,978.17 |
| 归属于母公司股东的净利润 | 553,338,118.91 | 403,523,612.05 | 184,296,095.55 | 492,431,974.71 |
| 少数股东损益 | -6,160,951.4 | -3,942,958.08 | -1,429,984.34 | -5,214,996.54 |
| (一)基本每股收益 | 4.49 | 3.27 | 2.23 | 6.81 |
| (二)稀释每股收益 | 4.49 | 3.27 | 2.23 | 6.81 |
| 八、其他综合收益 | -7,150,817.73 | 57,363.55 | -35,100.64 | -396,770.24 |
| 归属于母公司股东的其他综合收益 | -7,150,817.73 | 57,363.55 | -35,100.64 | -396,770.24 |
| 九、综合收益总额 | 540,026,349.78 | 399,638,017.52 | 182,831,010.57 | 486,820,207.93 |
| 归属于母公司股东的综合收益总额 | 546,187,301.18 | 403,580,975.6 | 184,260,994.91 | 492,035,204.47 |
| 归属于少数股东的综合收益总额 | -6,160,951.4 | -3,942,958.08 | -1,429,984.34 | -5,214,996.54 |
| 公告日期 | 2024-10-30 | 2024-08-27 | 2024-04-27 | 2024-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |